Mepolizumab for eosinophilic chronic obstructive pulmonary disease

Mepolizumab for eosinophilic chronic obstructive pulmonary disease

Patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.We performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizu...

Podrobná bibliografie
Hlavní autoři:	Pavord, I, Chanez, P, Criner, G, Kerstjens, H, Korn, S, Lugogo, N, Martinot, J, Sagara, H, Albers, F, Bradford, E, Harris, S, Mayer, B, Rubin, D, Yancey, S, Sciurba, F
Médium:	Journal article
Jazyk:	English
Vydáno:	Massachusetts Medical Society 2017

Podobné jednotky

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
Autor: Pavord, I, a další
Vydáno: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
Autor: Bafadhel, M, a další
Vydáno: (2018)

Mepolizumab for eosinophilic COPD
Autor: Sciurba, F, a další
Vydáno: (2018)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
Autor: Chapman, K, a další
Vydáno: (2018)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
Autor: Gunsoy, N, a další
Vydáno: (2017)

Mepolizumab treatment in patients with severe eosinophilic asthma.
Autor: Ortega, H, a další
Vydáno: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
Autor: Bel, E, a další
Vydáno: (2014)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
Autor: Shrimanker, R, a další
Vydáno: (2018)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
Autor: Mkorombindo T, a další
Vydáno: (2019-08-01)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Autor: Pavord, I, a další
Vydáno: (2012)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Autor: Bel, E, a další
Vydáno: (2014)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Autor: Steven W. Yancey, a další
Vydáno: (2019-09-01)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Autor: Ortega, H, a další
Vydáno: (2016)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Autor: Yancey, S, a další
Vydáno: (2016)

Mepolizumab in refractory eosinophilic asthma.
Autor: Pavord, I, a další
Vydáno: (2010)

Mepolizumab, quality of life, and severe eosinophilic asthma.
Autor: Pavord, I
Vydáno: (2017)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Autor: Howell, I, a další
Vydáno: (2024)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Autor: Prazma CM, a další
Vydáno: (2021-06-01)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Autor: Ian D. Pavord, a další
Vydáno: (2022-05-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Autor: Imran Howell, a další
Vydáno: (2024-07-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
Autor: Terufumi Shimoda, a další
Vydáno: (2017-07-01)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
Autor: Wechsler, M, a další
Vydáno: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
Autor: Moran, AM, a další
Vydáno: (2020)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Autor: Haldar, P, a další
Vydáno: (2009)

Response to mepolizumab treatment is sustained across 4-weekly dosing periods
Autor: Ian D. Pavord, a další
Vydáno: (2020-09-01)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
Autor: Mi-Kyeong Kim, a další
Vydáno: (2021-03-01)

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Autor: Frank C. Albers, a další
Vydáno: (2019-07-01)

Treatment of eosinophilic myositis with mepolizumab
Autor: Saadia Waheed, a další
Vydáno: (2018-01-01)

GLUCOLD, eosinophils and chronic obstructive pulmonary disease
Autor: Pavord, I
Vydáno: (2018)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Autor: Shrimanker, R, a další
Vydáno: (2017)

Biomarkers for severe eosinophilic asthma.
Autor: Yancey, S, a další
Vydáno: (2017)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
Autor: Menzella F, a další
Vydáno: (2016-06-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Autor: Shrimanker, R, a další
Vydáno: (2017)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
Autor: Moran, A, a další
Vydáno: (2020)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
Autor: Benjamin Terrier, a další
Vydáno: (2023-07-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
Autor: Chio Sakai, a další
Vydáno: (2024-07-01)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
Autor: Nina B. Curkovic, MD, a další
Vydáno: (2024-11-01)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
Autor: Ravi Ranjan Pradhan, a další
Vydáno: (2019-01-01)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
Autor: Ryota Otoshi, a další
Vydáno: (2020-03-01)

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
Autor: Ian Pavord, a další
Vydáno: (2023-04-01)